The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Advancing racial representation in clinical trials: An analysis of 53 ASCO plenary and late-breaking abstracts using the DRIVE score.
 
Samuel Ranger
Employment - IQVIA
 
Maya Birhiray
Employment - Hematology Oncology of Indiana (I)
Consulting or Advisory Role - Abbvie (I); Array BioPharma (I); Coherus BioSciences (I); Epizyme (I); Exelixis (I); Genentech (I); Ipsen (I); Janssen (I); Janssen Scientific Affairs (I); Lilly (I); Regeneron (I); Sanofi (I); Taiho Oncology (I); Takeda (I); TG Therapeutics (I)
Speakers' Bureau - Abbvie (I); Amgen (I); Astellas Oncology (I); AstraZeneca (I); BeiGene (I); Blueprint Medicines (I); Coherus BioSciences (I); Daiichi Sankyo (I); Dova Pharmaceuticals (I); E.R. Squibb Sons, LLC (I); Exelixis (I); Genzyme (I); GlaxoSmithKline (I); Incyte (I); Janssen Biotech (I); Lilly (I); Pfizer (I); Pharmacyclics (I); Puma Biotechnology (I); Regeneron (I); Sanofi (I); SERVIER (I); Stemline Therapeutics (I); Taiho Oncology (I)
Research Funding - Genentech (I); Regeneron (I); Takeda (I)
 
Ruemu Birhiray
Employment - Hematology Oncology of Indiana
Consulting or Advisory Role - Abbvie; Array BioPharma; Coherus Biosciences; Epizyme; Exelixis; Genentech; Ipsen; Janssen; Janssen Scientific Affairs; Lilly; Regeneron; Sanofi; Taiho Pharmaceutical; Takeda; TG Therapeutics
Speakers' Bureau - Abbvie; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Blueprint Medicines; Bristol-Myers Squibb; Coherus Biosciences; Daiichi Sankyo; Dova Pharmaceuticals; Exelixis; Genzyme; GlaxoSmithKline; Incyte; Janssen Oncology; Lilly; Pfizer; Pharmacyclics; Puma Biotechnology; Regeneron; Sanofi; SERVIER; Stemline Therapeutics; Taiho Pharmaceutical
Research Funding - Genentech; Regeneron; Takeda